Adrenal disease

Adrenal androgens as predictors of growth characteristics in premature pubarche

Eur J EndocrinolPublished Prospective cohort study

Authors' conclusion

Isolated idiopathic PP appears to be a benign variant of normal development. In this setting, adrenal androgen concentrations are not associated with adverse linear growth outcomes and are unlikely to influence clinical management, supporting a conservative approach after exclusion of pathological causes.

Study context

Population
Girls with isolated premature pubarche, assessed at presentation and during follow-up
Participants
53 vs 36
Exposure
Girls with isolated premature pubarche (PP) vs age-matched girls without PP
  • PPn = 53
  • Controlsn = 36reference
Outcome
Predictive value of adrenal androgens (DHEA, dehydroepiandrosterone-sulfate (DHEA-S), A4, androsterone, 11OHA4, 11OHT) for growth characteristics
Methodological detailsage-matched controls, liquid chromatography-mass spectrometry
  • Age-matched controls
  • Liquid chromatography-mass spectrometry

Main finding

As reported in the abstract

Correlation of adrenal androgens with height, corrected height and growth velocity · baseline and follow-up of 2.7 years

Corrected height SDS correlated with baseline corrected height SDS

r = .63

P < .0001

Corrected height SDS correlated with baseline bone age (BA)/chronological age ratio

r = .31

P = .02

Corrected height SDS correlated with baseline BA SDS

r = .32

P = .01

Observational data: associations, not effects.

Further findings

OutcomeP value
Height, BMI-SDS, DHEA, DHEA-S, A4, androsterone and 17OH-pregnenoloneHigher with PPP < 0.0001

11OHA4 and 11OHT concentrations

No difference in 11OHA4 and 11OHT between PP and controls

Original publication

Adrenal androgens as predictors of growth characteristics in premature pubarche. Eur J Endocrinol. Published 4 February 2026. doi:10.1093/ejendo/lvag024

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.